Amal El‐Shehaby

838 total citations
24 papers, 693 citations indexed

About

Amal El‐Shehaby is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Amal El‐Shehaby has authored 24 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Amal El‐Shehaby's work include Neonatal Health and Biochemistry (2 papers), Vitamin D Research Studies (2 papers) and Parathyroid Disorders and Treatments (2 papers). Amal El‐Shehaby is often cited by papers focused on Neonatal Health and Biochemistry (2 papers), Vitamin D Research Studies (2 papers) and Parathyroid Disorders and Treatments (2 papers). Amal El‐Shehaby collaborates with scholars based in Egypt, Malaysia and United Kingdom. Amal El‐Shehaby's co-authors include Mohamed El‐Khatib, Olfat Shaker, Abdel‐Rahman N. Zekri, Abeer A. Bahnassy, Samar Marzouk, Yasser Emad, Mostafa El-Serafi, Ghada M. Sherif, Nashwa El-Shaarawy and Soha M. Abd El Dayem and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Gastroenterology and Hepatology and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

Amal El‐Shehaby

24 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal El‐Shehaby Egypt 14 179 132 130 129 105 24 693
Sung Jig Lim South Korea 13 207 1.2× 70 0.5× 92 0.7× 198 1.5× 83 0.8× 26 709
Yunfeng Xia China 15 225 1.3× 68 0.5× 132 1.0× 174 1.3× 58 0.6× 37 643
Zhaohui Wang China 15 153 0.9× 128 1.0× 111 0.9× 67 0.5× 70 0.7× 53 599
Yuan‐Han Qin China 21 372 2.1× 60 0.5× 97 0.7× 275 2.1× 53 0.5× 54 943
R. Riess Germany 12 203 1.1× 85 0.6× 127 1.0× 233 1.8× 43 0.4× 22 705
Rujuan Xie China 16 194 1.1× 38 0.3× 209 1.6× 140 1.1× 62 0.6× 33 742
Carolina Lavoz Spain 15 352 2.0× 50 0.4× 181 1.4× 171 1.3× 50 0.5× 26 738
Yuzo Endo Japan 18 139 0.8× 62 0.5× 179 1.4× 189 1.5× 76 0.7× 37 741
Won Tae Chung South Korea 20 246 1.4× 53 0.4× 172 1.3× 125 1.0× 134 1.3× 59 914
Yan Xue China 16 249 1.4× 97 0.7× 137 1.1× 39 0.3× 75 0.7× 59 799

Countries citing papers authored by Amal El‐Shehaby

Since Specialization
Citations

This map shows the geographic impact of Amal El‐Shehaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal El‐Shehaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal El‐Shehaby more than expected).

Fields of papers citing papers by Amal El‐Shehaby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal El‐Shehaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal El‐Shehaby. The network helps show where Amal El‐Shehaby may publish in the future.

Co-authorship network of co-authors of Amal El‐Shehaby

This figure shows the co-authorship network connecting the top 25 collaborators of Amal El‐Shehaby. A scholar is included among the top collaborators of Amal El‐Shehaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal El‐Shehaby. Amal El‐Shehaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Khatib, Mohamed, et al.. (2019). Chemerin level and the relation to insulin resistance in chronic kidney disease. Saudi Journal of Kidney Diseases and Transplantation. 30(6). 1381–1381. 7 indexed citations
2.
El‐Shehaby, Amal, et al.. (2017). Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients. The Egyptian Heart Journal. 69(2). 149–155. 5 indexed citations
3.
Shaker, Olfat, et al.. (2013). Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4. Cell Biochemistry and Function. 31(7). 620–625. 7 indexed citations
4.
El‐Khatib, Mohamed, et al.. (2012). CRP and acute renal rejection: a marker to the point. International Urology and Nephrology. 44(4). 1251–1255. 13 indexed citations
5.
6.
Shaker, Olfat, et al.. (2011). Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. Clinical Biochemistry. 44(17-18). 1457–1463. 39 indexed citations
7.
Dayem, Soha M. Abd El, et al.. (2011). Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scandinavian Journal of Clinical and Laboratory Investigation. 71(5). 387–393. 49 indexed citations
8.
Shaker, Olfat, Amal El‐Shehaby, & Mohamed El‐Khatib. (2010). Early Diagnostic Markers for Contrast Nephropathy in Patients Undergoing Coronary Angiography. Angiology. 61(8). 731–736. 59 indexed citations
9.
10.
El‐Shehaby, Amal, et al.. (2010). Total and acylated ghrelin in liver cirrhosis: Correlation with clinical and nutritional status. Scandinavian Journal of Clinical and Laboratory Investigation. 70(4). 252–258. 12 indexed citations
11.
Hegazy, Mohamed Tharwat, et al.. (2010). Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices. Clinical Immunology. 135(1). 118–124. 40 indexed citations
12.
El‐Shehaby, Amal, et al.. (2010). Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients. Scandinavian Journal of Clinical and Laboratory Investigation. 70(8). 575–582. 32 indexed citations
13.
El‐Shehaby, Amal, et al.. (2010). Apelin: A potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scandinavian Journal of Clinical and Laboratory Investigation. 70(6). 421–427. 40 indexed citations
14.
El‐Khatib, Mohamed, et al.. (2009). The relation between dual energy x-ray absorptiometry measurement of body fat composition and plasma ghrelin in patients with end-stage renal disease.. PubMed. 30(1). 109–15. 7 indexed citations
15.
Aziz, M. T. Abdel, Taymour Mostafa, Hazem Atta, et al.. (2008). The Role of PDE5 Inhibitors in Heme Oxygenase–cGMP Relationship in Rat Cavernous Tissues. The Journal of Sexual Medicine. 5(7). 1636–1645. 27 indexed citations
16.
Aziz, M. T. Abdel, Taymour Mostafa, Hazem Atta, et al.. (2007). Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue. Andrologia. 39(2). 66–70. 18 indexed citations
17.
Bahnassy, Abeer A., et al.. (2005). Human papillomavirus infection in Egyptian esophageal carcinoma: Correlation with p53, p21waf, mdm2, C‐erbB2 and impact on survival. Pathology International. 55(2). 53–62. 34 indexed citations
18.
Zekri, Abdel‐Rahman N., Abeer A. Bahnassy, Mohamed M. Hafez, et al.. (2004). Alterations of the fragile histidine triad gene in hepatitis C virus‐associated hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 20(1). 87–94. 8 indexed citations
19.
Zekri, Abdel‐Rahman N., Waleed Mohamed, Mohamed Samra, et al.. (2004). Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transplant Immunology. 13(4). 305–311. 34 indexed citations
20.
Bahnassy, Abeer A., et al.. (2004). Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients. BMC Gastroenterology. 4(1). 22–22. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung Jig Lim Breakdown of academic impact, for papers by Yunfeng Xia Breakdown of academic impact, for papers by Zhaohui Wang Breakdown of academic impact, for papers by Yuan‐Han Qin Breakdown of academic impact, for papers by R. Riess Breakdown of academic impact, for papers by Rujuan Xie Breakdown of academic impact, for papers by Carolina Lavoz Breakdown of academic impact, for papers by Yuzo Endo Breakdown of academic impact, for papers by Won Tae Chung Breakdown of academic impact, for papers by Yan Xue
Rankless by CCL
2026